Correlation Between Aerovate Therapeutics and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Aerovate Therapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Pmv Pharmaceuticals.
Diversification Opportunities for Aerovate Therapeutics and Pmv Pharmaceuticals
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Aerovate and Pmv is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Pmv Pharmaceuticals
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.26 times more return on investment than Pmv Pharmaceuticals. However, Aerovate Therapeutics is 1.26 times more volatile than Pmv Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 186.00 in Aerovate Therapeutics on November 2, 2024 and sell it today you would earn a total of 76.00 from holding Aerovate Therapeutics or generate 40.86% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Aerovate Therapeutics vs. Pmv Pharmaceuticals
Performance |
Timeline |
Aerovate Therapeutics |
Pmv Pharmaceuticals |
Aerovate Therapeutics and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Pmv Pharmaceuticals
The main advantage of trading using opposite Aerovate Therapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |